JP2016501261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501261A5 JP2016501261A5 JP2015546419A JP2015546419A JP2016501261A5 JP 2016501261 A5 JP2016501261 A5 JP 2016501261A5 JP 2015546419 A JP2015546419 A JP 2015546419A JP 2015546419 A JP2015546419 A JP 2015546419A JP 2016501261 A5 JP2016501261 A5 JP 2016501261A5
- Authority
- JP
- Japan
- Prior art keywords
- mal
- ppi
- iii
- dendrimer
- maltotriose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000412 dendrimer Substances 0.000 claims 8
- 229920000736 dendritic polymer Polymers 0.000 claims 8
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims 6
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims 6
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims 6
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims 6
- 239000002245 particle Substances 0.000 claims 5
- 230000002159 abnormal effect Effects 0.000 claims 4
- 230000006907 apoptotic process Effects 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000002489 hematologic effect Effects 0.000 claims 4
- 230000007246 mechanism Effects 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 230000002062 proliferating effect Effects 0.000 claims 4
- 238000001990 intravenous administration Methods 0.000 claims 3
- 229920000333 poly(propyleneimine) Polymers 0.000 claims 3
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 2
- 239000004743 Polypropylene Substances 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 230000001613 neoplastic effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- -1 polypropylene Polymers 0.000 claims 2
- 229920001155 polypropylene Polymers 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 230000009925 apoptotic mechanism Effects 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007975 buffered saline Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002466 imines Chemical class 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000002504 physiological saline solution Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL401936A PL234888B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| PLP-401936 | 2012-12-06 | ||
| PCT/PL2013/000163 WO2014088435A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501261A JP2016501261A (ja) | 2016-01-18 |
| JP2016501261A5 true JP2016501261A5 (cg-RX-API-DMAC10.html) | 2017-01-26 |
Family
ID=49955472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015546419A Pending JP2016501261A (ja) | 2012-12-06 | 2013-12-06 | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9877985B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2928479A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2016501261A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20150093216A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013356793A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2893973A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL239144A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL234888B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014088435A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL234887B1 (pl) * | 2012-12-06 | 2020-04-30 | Univ Lodzki | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| PL416636A1 (pl) * | 2016-03-24 | 2017-09-25 | Univ Łódzki | Medyczne zastosowanie dendrymeru polipropylenoiminowego czwartej generacji, opłaszczonego maltotriozą |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090208580A1 (en) | 2005-09-19 | 2009-08-20 | Regents Of The University Of Michigan | Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| US20110177602A1 (en) * | 2007-06-27 | 2011-07-21 | Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG | Composite Structure |
| PL234887B1 (pl) * | 2012-12-06 | 2020-04-30 | Univ Lodzki | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
-
2012
- 2012-12-06 PL PL401936A patent/PL234888B1/pl unknown
-
2013
- 2013-12-06 CA CA2893973A patent/CA2893973A1/en not_active Abandoned
- 2013-12-06 EP EP13821004.2A patent/EP2928479A1/en not_active Withdrawn
- 2013-12-06 KR KR1020157018094A patent/KR20150093216A/ko not_active Withdrawn
- 2013-12-06 US US14/650,521 patent/US9877985B2/en not_active Expired - Fee Related
- 2013-12-06 JP JP2015546419A patent/JP2016501261A/ja active Pending
- 2013-12-06 AU AU2013356793A patent/AU2013356793A1/en not_active Abandoned
- 2013-12-06 WO PCT/PL2013/000163 patent/WO2014088435A1/en not_active Ceased
-
2015
- 2015-06-02 IL IL239144A patent/IL239144A0/en unknown